Amit Mahipal MBBS, MD, MPH

Amit Mahipal, MBBS, MPH, specializes in the treatment of gastrointestinal cancers. In particular, he specializes in the treatment of bile duct cancer, pancreatic cancer, liver cancer, colorectal cancer, Dr. Mahipal is also involved in the development of novel therapeutic agents for gastrointestinal cancers. He is a member of Phase 1 clinical trial program at Mayo Clinic and is involved in drug development for oncology patients. He is the principal investigator for several early phase clinical trials including first-in-human studies. He has spearheaded several investigator-initiated trials for pancreatic, liver, and bile duct cancers. He is involved in developing different markers that could potentially be utilized in developing personalized therapies in the field of oncology. In addition to his clinical and research activities, Dr. Mahipal is active in education, providing mentorship to residents and fellows. He authors expert content and publishes it in high-impact scientific journals.